The impact of dasatinib on pregnancy outcomes

American Journal of Hematology
Jorge E CortesJane F Apperley

Abstract

Prolonged survival in patients with chronic myeloid leukemia treated with BCR-ABL1-targeted tyrosine kinase inhibitors allows consideration of parenthood for patients on chronic therapy, but there are limited data about the effects of dasatinib on pregnancy. Pregnancy-related outcomes in dasatinib-treated patients or their partners reported to Bristol-Myers Squibb from clinical trials or healthcare providers through December 2013 were reviewed. Outcomes were available in 46/78 dasatinib-treated women (59%) and 33/69 partners of dasatinib-treated men (48%). Fifteen women (33%) delivered a normal infant; 18 (39%) and 8 (17%) had an elective or spontaneous abortion; and 5 (11%) had an abnormal pregnancy. There were 7 reports of fetal/infant abnormalities (encephalocele, renal tract abnormalities, and hydrops fetalis). Thirty of 33 (91%) infants fathered by dasatinib-treated men were reported normal at birth. Also, animal studies evaluated the impact of dasatinib on fertility, embryo-fetal toxicity, and development, suggesting that dasatinib may be a selective developmental toxicant. The outcomes of most pregnancies conceived by men treated with dasatinib were normal, but due to the small number of cases, further monitoring is requ...Continue Reading

References

Dec 1, 1988·The New England Journal of Medicine·I Hertz-Picciotto, S J Samuels
Jul 28, 1988·The New England Journal of Medicine·A J WilcoxB C Nisula
Jun 23, 2000·BMJ : British Medical Journal·A M Nybo AndersenM Melbye
Jan 27, 2005·American Journal of Obstetrics and Gynecology·Cande V AnanthAnthony M Vintzileos
Feb 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia AultJorge Cortes
Apr 5, 2007·Haematologica·Laurent GarderetNorbert Claude Gorin
Mar 7, 2008·Blood·Seonaid M PyeJane F Apperley
Mar 22, 2008·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·Ronan O'Rahilly, Fabiola Müller
Jun 27, 2008·Journal of the American Medical Informatics Association : JAMIA·Daijin KimSamuel H Holliday
Sep 13, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kan HeLisa J Christopher
Oct 22, 2008·Leukemia Research·Federica SoràSimona Sica
Nov 11, 2008·Developmental Biology·Avenel JosephBarry T Hinton
May 18, 2010·Archives of Gynecology and Obstetrics·Houssam OweiniAli Bazarbachi
Mar 17, 2012·Anti-cancer Drugs·Paul BerveillerVassilis Tsatsaris
Apr 19, 2012·Birth Defects Research. Part A, Clinical and Molecular Teratology·Lyndsay Ammon AvalosDe-Kun Li
May 8, 2014·Mediterranean Journal of Hematology and Infectious Diseases·Elisabetta AbruzzesePaolo De Fabritiis

❮ Previous
Next ❯

Citations

Jul 14, 2016·Journal of Advanced Research·Hossam K MahmoudGamal M Fathy
Jun 30, 2016·Expert Review of Hematology·Elisabetta AbruzzeseMichele Baccarani
Aug 27, 2016·Leukemia & Lymphoma·Lauren Caldemeyer, Luke P Akard
Nov 9, 2016·Critical Reviews in Oncology/hematology·Elena LorenziArmando Santoro
Feb 17, 2017·Journal of Adolescent and Young Adult Oncology·Angela DautiAntoinette Anazodo
Jul 14, 2017·Leukemia & Lymphoma·Ekaterina ChelyshevaGhermes Chilov
Feb 27, 2018·Expert Opinion on Emerging Drugs·Simon KavanaghJeffrey H Lipton
Feb 16, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ellin BermanRichard Burwick
Dec 12, 2017·Obstetric Medicine·Mathieu PuyadeOlivier Pourrat
Dec 7, 2017·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·David J HermelMojtaba Akhtari
Nov 9, 2018·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·Till WeidnerSonja Grunewald
Nov 6, 2018·American Journal of Hematology·Jorge CortesJeffrey H Lipton
Dec 19, 2018·Journal of Clinical Medicine·Claudio Ponticelli, Gabriella Moroni
Jan 24, 2019·European Journal of Haematology·Ekaterina Chelysheva, Anna Turkina
Dec 6, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neil P Shah
Oct 5, 2019·Journal of Global Oncology·Irappa MadabhaviNagaveni Kadakol
May 19, 2020·Japanese Journal of Clinical Oncology·Masahiro Ashizawa, Yoshinobu Kanda
Aug 1, 2020·British Journal of Haematology·Graeme SmithUNKNOWN British Society for Haematology
Jun 27, 2020·International Journal of Molecular Sciences·Francesca CarofiglioFrancesco Leonetti
Dec 30, 2017·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Theodora Barkoulas, Philip D Hall
Jun 6, 2017·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Sandra CuellarDaniel Olszta
Jan 19, 2019·Molecular and Clinical Oncology·Merav BarzilaiOdelia Amit
Nov 8, 2018·European Journal of Haematology·Elisabetta AbruzzeseMichael J Mauro
Nov 9, 2019·Current Hematologic Malignancy Reports·Naranie Shanmuganathan, Timothy P Hughes
Jul 30, 2019·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Michael J ReffJulie Kennerly-Shah
May 8, 2020·Nature Reviews. Clinical Oncology·David M Ross, Timothy P Hughes
Nov 1, 2016·The Journal of Clinical Investigation·Yoshinori MatsumotoRobert Rottapel
Oct 3, 2020·International Journal of Hematologic Oncology·Jorge E CortesTim H Brümmendorf
Sep 11, 2020·JCO Oncology Practice·Jordyn SilversteinKatherine Van Loon
Oct 7, 2020·Journal of the National Comprehensive Cancer Network : JNCCN·Michael W DeiningerHema Sundar
Oct 13, 2020·Hematology Reports·Matteo MolicaElisabetta Abruzzese
Nov 29, 2020·BMC Biology·Joanna RutkowskaShinichi Nakagawa
Dec 21, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Maha Al-AsmakhAla-Eddin Al Moustafa
Nov 3, 2020·HemaSphere·Rüdiger Hehlmann
Nov 17, 2020·Therapeutic Advances in Hematology·Elisabetta AbruzzeseEkaterina Chelysheva
Nov 20, 2020·Journal of Clinical Medicine·Rüdiger Hehlmann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.